Parsley Health has launched a new program that focuses on providing comprehensive care for working women with complex and chronic health concerns. The program aims to deliver exceptional health outcomes by addressing a wide range of medical conditions, including autoimmune, gastrointestinal, cardiometabolic, behavioral health, and hormonal conditions. It covers women throughout their reproductive health to menopause and combines high-touch, tech-enabled virtual care…
BNY Mellon Investment Management, an asset management firm with $1.9 trillion in assets under management is launching the BNY Mellon Women’s Opportunities ETF (ticker: BKWO) today. Listed on Nasdaq, the ETF is sub-advised by Newton Investment Management North America, a BNY Mellon investment firm and aa equity and multi-asset manager. “This addition to our growing suite of ETFs provides investors with access to Newton’s…
InsideTracker, a personal health analysis and data-driven wellness guide that helps people increase their healthspan and live healthier longer, announced that the company’s popular Ultimate Plan will now provide female users with analysis and optimization guidance for three new biomarkers pivotal to increasing women’s healthspan and navigating menopause. Founded in 2009 and created by experts in the fields of aging, genetics, and biometric data,…
Bonatra, a healthtech startup, has recently announced its acquisition of MyAva, a women’s health and wellness company. This move is aimed at expanding Bonatra’s holistic healthcare programs, and establishing it as a comprehensive platform for managing chronic health conditions. MyAva is a femtech startup that offers curated programs and personalized plans to help women manage chronic health conditions such as PCOS, thyroid…
Health Innovation Network is the Academic Health Science Network (AHSN) for south London – 1 of 15 AHSNs across England. As the only bodies that connect NHS and academic organisations, local authorities, the third sector and industry, HIH is uniquely placed to increase the spread and adoption of innovation across large populations, at pace and scale. Now the network, that is also…
Pharma giant Bayer has announced that it will shift the focus of its drug research away from women’s health and towards neurology, rare diseases, and immunology. According to Reuters Stefan Oelrich, head of Bayer’s pharmaceuticals unit, stated that the company will no longer have an explicit focus on women’s health during research and clinical phases. However, Bayer, maker of the Yasmin brand…
Femtech Pulse is a collection of short stories and wins from your favorite femtech startups, innovators, and investors! Wanna pitch us a story and feature in our next round-up? Get in touch! MedArrive Partners with Ouma MedArrive, the leading mobile-integrated care management solution, today announced a partnership with Ouma Health, a total maternity telehealth services company, to bring comprehensive maternal-fetal care directly into the…
Fount, a company specializing in experiment-driven health and performance optimization, has announced a successful $12M Series A fundraise to expand its mission of making personalized health and performance optimization programs more widely available. The round was led by Amity Ventures with participation from Elysian Park Ventures, Not Boring Capital, Allen & Co, Champion Hill Ventures, and angel investors. The company initially began…
